Effectiveness of the Exhalation Delivery System with Fluticasone for Treating Chronic Rhinosinusitis with Nasal Polyposis: a Systematic Review and Meta-analysis

Overview

Journal Eur Arch Otorhinolaryngol

Specialty Otorhinolaryngology

Date 2024 Nov 21

PMID 39572411

Authors

Yun Jin Kang

Gulnaz Stybayeva

Se Hwan Hwang

Affiliations

Soon will be listed here.

Abstract

Purpose: We evaluated the effects of two doses (186 µg and 372 µg) of exhalation delivery system with fluticasone (EDS-FLU) on chronic rhinosinusitis (CRS) with nasal polyp as a novel sinonasal delivery system.

Methods: We analyzed 5 studies retrieved from PubMed, SCOPUS, Embase, Web of Science, and Cochrane databases up to April 2024, focusing on subjective and objective scores, and adverse and beneficial effects (responder and complete responder rates, improvements in Patient Global Impression of Change [PGIC] scores, and surgical indication rates before and after EDS-FLU use.

Results: Over 3 months, EDS-FLU significantly reduced polyp (mean difference [MD] - 1.1605; 95% confidence interval [CI] [- 1.3277; -0.9934], I = 61.4%) and 22-item Sinonasal Outcome Test (MD - 20.7561; 95% CI [- 22.3473; -19.1648], I = 0.0%) scores compared to baseline. At 1 month, nasal congestion, facial pain, olfactory dysfunction, and rhinorrhea significantly improved compared to baseline. EDS-FLU significantly reduced the surgical indication rate (odds ratio 0.2594; 95% CI [0.1910; 0.3522], I = 0.0%) and improved patient satisfaction, with 63.34% of patients reporting significant improvement in PGIC scores after 3 months. However, adverse effects, including epistaxis, headache, nasal congestion, and nasopharyngitis, were reported, with incidence rates ranging from 4.46 to 8.99%. There were no significant differences in beneficial or adverse effects between high and low fluticasone doses, but the high dose was associated with a higher percentage of complete responders.

Conclusion: Both doses of EDS-FLU significantly improved subjective and objective outcomes of CRS patients with nasal polyps. However, epistaxis and nasal septal erosive or ulcerative lesions were also considered.

References

Hamilos D . Chronic rhinosinusitis: epidemiology and medical management. J Allergy Clin Immunol. 2011; 128(4):693-707. DOI: 10.1016/j.jaci.2011.08.004. View

Dietz de Loos D, Lourijsen E, Wildeman M, Freling N, Wolvers M, Reitsma S . Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology. J Allergy Clin Immunol. 2018; 143(3):1207-1214. DOI: 10.1016/j.jaci.2018.12.986. View

Smith K, Orlandi R, Rudmik L . Cost of adult chronic rhinosinusitis: A systematic review. Laryngoscope. 2015; 125(7):1547-56. DOI: 10.1002/lary.25180. View

Orlandi R, Kingdom T, Hwang P . International Consensus Statement on Allergy and Rhinology: Rhinosinusitis Executive Summary. Int Forum Allergy Rhinol. 2016; 6 Suppl 1:S3-21. DOI: 10.1002/alr.21694. View

Akdis C, Bachert C, Cingi C, Dykewicz M, Hellings P, Naclerio R . Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2013; 131(6):1479-90. PMC: 4161279. DOI: 10.1016/j.jaci.2013.02.036. View

Lam K, Schleimer R, Kern R . The Etiology and Pathogenesis of Chronic Rhinosinusitis: a Review of Current Hypotheses. Curr Allergy Asthma Rep. 2015; 15(7):41. PMC: 4874491. DOI: 10.1007/s11882-015-0540-2. View

Hull B, Chandra R . Refractory Chronic Rhinosinusitis with Nasal Polyposis. Otolaryngol Clin North Am. 2016; 50(1):61-81. DOI: 10.1016/j.otc.2016.08.006. View

Waljee A, Rogers M, Lin P, Singal A, Stein J, Marks R . Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ. 2017; 357:j1415. PMC: 6284230. DOI: 10.1136/bmj.j1415. View

Van Zele T, Gevaert P, Holtappels G, Beule A, John Wormald P, Mayr S . Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010; 125(5):1069-1076.e4. DOI: 10.1016/j.jaci.2010.02.020. View

10.

Vaidyanathan S, Barnes M, Williamson P, Hopkinson P, Donnan P, Lipworth B . Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: a randomized trial. Ann Intern Med. 2011; 154(5):293-302. DOI: 10.7326/0003-4819-154-5-201103010-00003. View

11.

Djupesland P, Skretting A . Nasal deposition and clearance in man: comparison of a bidirectional powder device and a traditional liquid spray pump. J Aerosol Med Pulm Drug Deliv. 2012; 25(5):280-9. DOI: 10.1089/jamp.2011.0924. View

12.

Siu J, Johnston J, Pontre B, Inthavong K, Douglas R . Magnetic resonance imaging evaluation of the distribution of spray and irrigation devices within the sinonasal cavities. Int Forum Allergy Rhinol. 2019; 9(9):958-970. DOI: 10.1002/alr.22376. View

13.

Djupesland P . Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review. Drug Deliv Transl Res. 2013; 3(1):42-62. PMC: 3539067. DOI: 10.1007/s13346-012-0108-9. View

14.

Aggarwal R, Cardozo A, Homer J . The assessment of topical nasal drug distribution. Clin Otolaryngol Allied Sci. 2004; 29(3):201-5. DOI: 10.1111/j.1365-2273.2004.00797.x. View

15.

Baguley C, Brownlow A, Yeung K, Pratt E, Sacks R, Harvey R . The fate of chronic rhinosinusitis sufferers after maximal medical therapy. Int Forum Allergy Rhinol. 2014; 4(7):525-32. DOI: 10.1002/alr.21315. View

16.

Palmer J, Messina J, Biletch R, Grosel K, Mahmoud R . A cross-sectional, population-based survey of U.S. adults with symptoms of chronic rhinosinusitis. Allergy Asthma Proc. 2018; 40(1):48-56. DOI: 10.2500/aap.2019.40.4182. View

17.

Harvey R, Debnath N, Srubiski A, Bleier B, Schlosser R . Fluid residuals and drug exposure in nasal irrigation. Otolaryngol Head Neck Surg. 2009; 141(6):757-61. DOI: 10.1016/j.otohns.2009.09.006. View

18.

Kennedy D . Defining quality in chronic rhinosinusitis management. Int Forum Allergy Rhinol. 2018; 8(12):1367-1368. DOI: 10.1002/alr.22254. View

19.

Bernstein J, White A, Han J, Lang D, Elkayam D, Baroody F . Review of evidence supporting the use of nasal corticosteroid irrigation for chronic rhinosinusitis. Ann Allergy Asthma Immunol. 2022; 130(1):46-57. DOI: 10.1016/j.anai.2022.09.008. View

20.

Rudmik L, Soler Z, Hopkins C, Schlosser R, Peters A, White A . Defining appropriateness criteria for endoscopic sinus surgery during management of uncomplicated adult chronic rhinosinusitis: a RAND/UCLA appropriateness study. Int Forum Allergy Rhinol. 2016; 6(6):557-67. DOI: 10.1002/alr.21769. View